79MO PACIFIC-R: Real-world characteristics of unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

This article has no abstract
Epistemonikos ID: 6a87abfa95af27ccb88e90d34fad4b192efe44e8
First added on: Feb 13, 2025